LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Broad Kinase Inhibition Mitigates Early Neuronal Dysfunction in Tauopathy

Shon A. Koren / Matthew J. Hamm / Ryan Cloyd / Sarah N. Fontaine / Emad Chishti / Chiara Lanzillotta / Jennifer Rodriguez-Rivera / Alexandria Ingram / Michelle Bell / Sara M. Galvis-Escobar / Nicholas Zulia / Fabio Di Domenico / Duc Duong / Nicholas T. Seyfried / David Powell / Moriel Vandsburger / Tal Frolinger / Anika M. S. Hartz / John Koren /
Jeffrey M. Axten / Nicholas J. Laping / Jose F. Abisambra

International Journal of Molecular Sciences, Vol 22, Iss 3, p

2021  Volume 1186

Abstract: Tauopathies are a group of more than twenty known disorders that involve progressive neurodegeneration, cognitive decline and pathological tau accumulation. Current therapeutic strategies provide only limited, late-stage symptomatic treatment. This is ... ...

Abstract Tauopathies are a group of more than twenty known disorders that involve progressive neurodegeneration, cognitive decline and pathological tau accumulation. Current therapeutic strategies provide only limited, late-stage symptomatic treatment. This is partly due to lack of understanding of the molecular mechanisms linking tau and cellular dysfunction, especially during the early stages of disease progression. In this study, we treated early stage tau transgenic mice with a multi-target kinase inhibitor to identify novel substrates that contribute to cognitive impairment and exhibit therapeutic potential. Drug treatment significantly ameliorated brain atrophy and cognitive function as determined by behavioral testing and a sensitive imaging technique called manganese-enhanced magnetic resonance imaging (MEMRI) with quantitative R1 mapping. Surprisingly, these benefits occurred despite unchanged hyperphosphorylated tau levels. To elucidate the mechanism behind these improved cognitive outcomes, we performed quantitative proteomics to determine the altered protein network during this early stage in tauopathy and compare this model with the human Alzheimer’s disease (AD) proteome. We identified a cluster of preserved pathways shared with human tauopathy with striking potential for broad multi-target kinase intervention. We further report high confidence candidate proteins as novel therapeutically relevant targets for the treatment of tauopathy. Proteomics data are available via ProteomeXchange with identifier PXD023562.
Keywords tau ; GSK2606414 ; kinases ; MEMRI ; TMT proteomics ; Biology (General) ; QH301-705.5 ; Chemistry ; QD1-999
Subject code 616
Language English
Publishing date 2021-01-01T00:00:00Z
Publisher MDPI AG
Document type Article ; Online
Database BASE - Bielefeld Academic Search Engine (life sciences selection)

More links

Kategorien

To top